Issue navigation
Volume 5, Issue 2, April 2023
Original Article
In vitro activity of eravacycline and comparator agents against bacterial pathogens isolated from patients with cancer
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad020, https://doi.org/10.1093/jacamr/dlad020
Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearance
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad011, https://doi.org/10.1093/jacamr/dlad011
Rapid molecular detection of CMY-2, and CTX-M group 1 and 9 variants via recombinase polymerase amplification
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad023, https://doi.org/10.1093/jacamr/dlad023
Re-evaluation of cefepime or piperacillin/tazobactam to decrease use of carbapenems in ESBL-producing Enterobacterales urinary tract infections (REDUCE-UTI)
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad021, https://doi.org/10.1093/jacamr/dlad021
Antibiotic consumption trends in Ghana: analysis of six-years pharmacy issue data from a secondary healthcare facility
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad025, https://doi.org/10.1093/jacamr/dlad025
Aztreonam/avibactam activity against a large collection of carbapenem-resistant Enterobacterales (CRE) collected in hospitals from Europe, Asia and Latin America (2019–21)
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad032, https://doi.org/10.1093/jacamr/dlad032
Impact of ompk36 genotype and KPC subtype on the in vitro activity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam against KPC-producing K. pneumoniae clinical isolates
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad022, https://doi.org/10.1093/jacamr/dlad022
Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad033, https://doi.org/10.1093/jacamr/dlad033
Characterization of vancomycin-resistance vanD gene clusters in the human intestinal microbiota by metagenomics and culture-enriched metagenomics
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad026, https://doi.org/10.1093/jacamr/dlad026
Development of a local antibiogram for a teaching hospital in Ghana
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad024, https://doi.org/10.1093/jacamr/dlad024
Accuracy of antibacterial indication documentation in an electronic medicines management system
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad028, https://doi.org/10.1093/jacamr/dlad028
The in vitro activity of delafloxacin and comparator agents against bacterial pathogens isolated from patients with cancer
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad034, https://doi.org/10.1093/jacamr/dlad034
Recurrent spontaneous Escherichia coli meningitis in an adult: a case report
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad029, https://doi.org/10.1093/jacamr/dlad029
Expert consensus on monitoring antimicrobial stewardship in French nursing homes using assessed reimbursement database indicators
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad037, https://doi.org/10.1093/jacamr/dlad037
Inclusion of minor alleles improves catalogue-based prediction of fluoroquinolone resistance in Mycobacterium tuberculosis
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad039, https://doi.org/10.1093/jacamr/dlad039
T2Candida assay: diagnostic performance and impact on antifungal prescribing
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad035, https://doi.org/10.1093/jacamr/dlad035
Intravesical aminoglycoside instillations as prophylaxis for recurrent urinary tract infection: patient satisfaction, long-term safety and efficacy
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad040, https://doi.org/10.1093/jacamr/dlad040
Association between piperacillin/tazobactam MIC and survival among hospitalized patients with Enterobacterales infections: retrospective cohort analysis of electronic health records from 161 US hospitals
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad041, https://doi.org/10.1093/jacamr/dlad041
Meningitis caused by extended-spectrum β-lactamase-producing Escherichia coli in infants in France: a case series
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad042, https://doi.org/10.1093/jacamr/dlad042
High incidence of carbapenemase-producing Pseudomonas aeruginosa clinical isolates from Lagos, Nigeria
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad038, https://doi.org/10.1093/jacamr/dlad038
The alginate polymer OligoG alters susceptibility of biofilm-embedded non-typeable Haemophilus influenzae to ampicillin and ciprofloxacin
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad046, https://doi.org/10.1093/jacamr/dlad046
Empirical use of temocillin in hospitalized patients: results from a retrospective audit
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad030, https://doi.org/10.1093/jacamr/dlad030
Cost analysis of dalbavancin versus standard of care for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in two Italian hospitals
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad044, https://doi.org/10.1093/jacamr/dlad044
Regional and national antimicrobial stewardship activities: a survey from the Joint Programming Initiative on Antimicrobial Resistance—Primary Care Antibiotic Audit and Feedback Network (JPIAMR-PAAN)
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad048, https://doi.org/10.1093/jacamr/dlad048
Association between minimum inhibitory concentration values and mortality risk in patients with Stenotrophomonas maltophilia infections: a retrospective cohort study of electronic health records from 148 US hospitals
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad049, https://doi.org/10.1093/jacamr/dlad049
Review
Mitigating antimicrobial resistance (AMR) using implementation research: a development funder’s approach
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad031, https://doi.org/10.1093/jacamr/dlad031
Can precision antibiotic prescribing help prevent the spread of carbapenem-resistant organisms in the hospital setting?
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad036, https://doi.org/10.1093/jacamr/dlad036
Impact of childhood malnutrition and intestinal microbiota on MDR infections
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad051, https://doi.org/10.1093/jacamr/dlad051
Educational resource review
Full review of online resources
Penicillin-allergy delabelling resources for clinicians practicing in resource-limited settings: a full educational resource review of the grey literature
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad014, https://doi.org/10.1093/jacamr/dlad014
Viewpoint
Implementation research for promoting access and rational use of antibiotics for children: lessons learnt from Tanzania
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad045, https://doi.org/10.1093/jacamr/dlad045
Correspondence
Can fosfomycin be an alternative therapy for infections caused by E. coli harbouring dual resistance: NDM and four-amino acid insertion in PBP3?
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad016, https://doi.org/10.1093/jacamr/dlad016
Assessment of ceftolozane/tazobactam degradation profile and toxicity data in elastomeric devices for continuous infusion via outpatient parenteral antimicrobial therapy (OPAT)
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad047, https://doi.org/10.1093/jacamr/dlad047
Comment on: Gaps and barriers in the implementation and functioning of antimicrobial stewardship programmes: results from an educational and behavioural mixed methods needs assessment in France, the United States, Mexico and India
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad050, https://doi.org/10.1093/jacamr/dlad050
Correction
Correction to: Prevalence and antimicrobial resistance patterns of Enterococcus species isolated from laying hens in Lusaka and Copperbelt provinces of Zambia: a call for AMR surveillance in the poultry sector
JAC-Antimicrobial Resistance, Volume 5, Issue 2, April 2023, dlad027, https://doi.org/10.1093/jacamr/dlad027
